Myoclonus and sedation on morphine in combined renal and hepatic failure
Mr. R is 68 with unresectable pancreatic cancer and new liver metastases. Labs: creatinine 2.4 mg/dL, eGFR 26 mL/min/1.73 m2, total bilirubin 3.1 mg/dL, albumin 2.6 g/dL. He takes morphine ER 30 mg PO every 12 hours plus morphine 15 mg PO every 2 hours as needed, averaging five rescue doses a day. He rates a constant deep epigastric ache with burning radiation to the back at 7/10. Over 72 hours he has developed twitching of the arms and legs, multifocal myoclonus, and increasing daytime sleepiness; his wife says he 'jerks' when she touches him. He is alert and oriented, answers questions appropriately, and says his goal is to be 'clear enough to talk with my brother.'
1. Calculate his current 24-hour opioid intake and explain what is driving the myoclonus and sedation. What is your assessment?
Read the worked answer
Current intake: 30 mg ER x 2 = 60 mg, plus 15 mg x 5 rescue = 75 mg, for 135 mg oral morphine per 24 hours.
What is driving the picture. This is not simply 'cancer progression' or 'he needs a bigger dose.' Three findings point to opioid metabolite accumulation:
- Myoclonus, multifocal twitching, and allodynia ('jerks when touched') are the classic signature of morphine-3-glucuronide neuroexcitation.
- Rising daytime sedation with a pain score that is still 7/10 suggests morphine-6-glucuronide accumulation.
- eGFR 26 and bilirubin 3.1 both impair clearance of parent drug and metabolites, and albumin 2.6 raises the free (active) fraction.
Exclude the mimics before settling: hypercalcemia, uremia (check BUN), hyponatremia, hypercapnia, benzodiazepine or antihistamine burden, new brain metastases, and dehydration.
Assessment: opioid neurotoxicity from morphine in the setting of combined renal and hepatic impairment, layered on an untreated neuropathic/visceral component that is driving the escalating rescue use. Escalating the morphine would deepen the sedation and worsen the myoclonus. The correct move is rotation plus treatment of the neuropathic component - not dose escalation.
2. Propose a specific opioid plan for the next 24-48 hours, including conversions, and explain why you are not choosing certain agents.
Read the worked answer
Principles: (1) stop the morphine; (2) rotate to a drug without clinically significant renally cleared active metabolites; (3) reduce the calculated equianalgesic dose 25-50% for incomplete cross-tolerance; (4) titrate against the patient's response, not against the arithmetic.
Preferred: fentanyl, SC or IV. Useful anchors: 30 mg oral morphine ~ 10 mg IV morphine ~ 100 mcg IV fentanyl. So 135 mg oral morphine/24 h ~ 450 mcg fentanyl/24 h ~ 18-19 mcg/h. Reduce for cross-tolerance and start around 10 mcg/h by continuous SC or IV infusion with 10-25 mcg boluses every 15-30 minutes as needed, reassessing at least every 4 hours. The key reason fentanyl is first choice here: it has no active renally eliminated metabolites.
If the oral route is mandatory: hydromorphone, roughly 5:1 from oral morphine, gives ~27 mg/24 h; reduce ~30% and start about 18 mg/24 h (for example 2 mg PO q4h scheduled with 1 mg PO q2h PRN). Acceptable but less ideal - hydromorphone-3-glucuronide accumulates somewhat in renal failure.
Do not: continue or increase morphine; use codeine or meperidine; start a transdermal fentanyl patch now - uncontrolled pain requiring rapid titration is exactly what a patch cannot deliver, and cachexia makes absorption unpredictable. Avoid oxycodone given the hepatic impairment and its active metabolite. Methadone is a reasonable later option for refractory pain but needs expertise and ECG monitoring.
Give a scheduled bowel regimen, and reassess sedation scale, respiratory rate, pain score, and myoclonus every 4 hours. The myoclonus should begin to improve within 24-48 hours of removing the morphine.
3. What non-opioid and monitoring plan would you add, and what would you tell the family about these symptoms?
Read the worked answer
- Visceral/capsular component: dexamethasone 4-8 mg PO or IV daily - reduces peritumoral edema and stretch on the liver capsule and can lower opioid requirement within 48-72 hours. Monitor glucose and mood.
- Neuropathic component: renally dose gabapentin. At eGFR 26, start 100-300 mg once daily and titrate slowly; pregabalin 25-50 mg daily is an alternative. If pain stays visceral-dominant, refer for celiac plexus neurolysis - it can meaningfully reduce opioid needs.
- Acetaminophen scheduled, but cap at 2 g/day given bilirubin 3.1 and hepatic metastases.
- Constipation prophylaxis: senna plus polyethylene glycol; methylnaltrexone only if refractory.
- Monitoring: sedation and respiratory rate one hour after every change, then q4h when stable; pain q4h; myoclonus; urine output; BUN and calcium.
- What to tell the wife: the jerking and sleepiness come from the drug building up because his kidneys and liver cannot clear it - not from the cancer suddenly accelerating - and they usually improve within a day or two of the switch. Say plainly that you are not trading his comfort for alertness; the plan is built to make him both comfortable and clear enough to talk with his brother. If alertness does not improve after rotation and metabolic causes are excluded, revisit the goals-of-care conversation.